Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical was founded in 1925. It entered into a strategic alliance with Roche in October 2002, becoming a member of the Roche Group.

As a drug manufacturer and a pioneer in biotechnological and pharmaceutical research, Chugai is a leading presence in the Japanese therapeutic antibody market and has gained reputation worldwide for its proprietary antibody engineering technologies.

Chugai has over 7,500 employees and has its headquarters situated in Tokyo, Japan.

More from the Roche Group

Get to know our structure

Discover more


This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement